ARANK heads into the final days of April on a soft footing — down nearly 2.5% on the week and 6% lower over the past month — with its next earnings event approaching on June 25.
The price action tells a quiet but persistent story of erosion. ARANK closed at MYR 0.395 on April 28, recovering just over 1% on the day but unable to arrest a month-long slide that has carried the stock from around MYR 0.42 toward the lower end of its recent range. With a market cap of approximately USD 17.9 million, this is a micro-cap name on Bursa Malaysia — thinly traded, low in institutional visibility, and sensitive to sentiment shifts even when the underlying fundamentals are unchanged.
No short interest data is available for ARANK through ORTEX — a common feature of Malaysian-listed small caps where securities lending infrastructure is limited. There are no cost-to-borrow or availability readings to parse. The absence of a lending market also means there is no short-covering pressure to consider in either direction. What drives the price here is almost entirely discretionary buying or selling among a concentrated shareholder base.
That concentration is striking. The top two registered holders — Chong Howa Leow at roughly 25% and Chih-Chang Lin at 21% — together control nearly half the company. A third holder, Wan Lay Tan, holds a further 10.5%. All three positions were last reported as of September 30, 2025, with no changes recorded. Collectively, the top shareholders hold shares that appear largely static, which limits the free float substantially and reinforces the stock's illiquid character. HSBC Global Asset Management (Singapore) appears in the register at around 2.4%, but this is one of very few institutional names present. The data is now over seven months old and should be treated as directional rather than current.
Insider activity provides little fresh signal. The most recent trade on record dates to November 2022, when an Executive Director sold 200,000 shares at MYR 0.53 — well above the current price. All other recorded transactions are from 2021 and reflect a period when the stock was trading between MYR 0.60 and MYR 0.80. The insider data is too stale to draw any current conclusions from.
One data point worth noting is the dividend score, which ORTEX ranks in the 74th percentile relative to the sector. A-Rank has paid annual cash dividends consistently since at least 2017, though the most recent declared dividend dates to September 2021 (MYR 0.0225 per share, paid December 2021). No dividend has been recorded since, which creates a gap between the score and the recent track record — the percentile ranking likely reflects the historical pattern rather than a current payout commitment. At MYR 0.395, the stock's historical yield from pre-2022 dividends would have been meaningful relative to the share price, but prospective income investors will be watching the next earnings report for any resumption of distributions.
The earnings history offers a consistent pattern without offering comfort. The last four events all produced negative five-day reactions: -10.1%, -4.8%, -2.5%, and -4.9%. The single-day moves have been modest — one session saw a drop of 6.7%, others were flat — but the drift in the days following each announcement has been reliably downward. Whether that reflects earnings disappointment or simply thin liquidity magnifying post-event selling is hard to separate. The June 25 report is the next milestone to watch, alongside any signal on whether the dividend policy has resumed.
See the live data behind this article on ORTEX.
Open ARANK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
